Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharOS is a privately owned pharmaceutical company headquartered in Greece, specializing in the development, registration, and life-cycle management of generic and value-added medicines. The company operates primarily through a B2B model, providing a comprehensive suite of services including product development, regulatory affairs, and business development to global pharmaceutical partners. PharOS maintains a robust portfolio of over 100 products across diverse therapeutic areas such as oncology, cardiovascular, and the central nervous system. With a strong emphasis on research and development, the firm focuses on delivering high-quality, cost-effective healthcare solutions and complex generic formulations to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharOS Pharmaceutical Oriented Services.